WALTHAM, Mass., June 4 /PRNewswire-FirstCall/ -- Thermo Fisher
Scientific Inc. (NYSE: TMO), the world leader in serving science, will
unveil its expanded line of LTQ Orbitrap(TM) mass spectrometers, as well as
other new research and discovery solutions, at the American Society for
Mass Spectrometry (ASMS) Conference being held June 3 - 7 in Indianapolis,
Ind. The new introductions reflect Thermo Fisher Scientific's continuing
commitment to deliver innovative mass spectrometry technologies to every
laboratory, from complex research and discovery applications to routine
testing.
New product highlights at the conference from the company's Thermo
Scientific brand include:
-- Thermo Scientific LTQ Orbitrap XL(TM): This new system builds on our
original LTQ Orbitrap to deliver even higher levels of performance for
both protein identification and biomarker discovery. New HCD octopole
collision cell technology provides superior capability for challenging
protein post-translational modification analysis, supporting both
labeled and label-free peptide quantitation. The system offers multiple
collision modes for definitive MSn structural characterization of small
molecules. Orbitrap XL delivers improved sensitivity in MS and MSn,
rapid scan rates, higher mass accuracy and resolving powers of up to
100,000. It is compatible with, and upgradeable to, an Electron
Transfer Dissociation (ETD) option for controlled dissociation of
peptides and proteins in advanced proteomics research.
-- Thermo Scientific LTQ Orbitrap Discovery(TM): This new configuration
brings Orbitrap technology into the price range of high-end Q-TOF
systems, providing a cost-effective alternative for general proteomics
and metabolomics applications. The LTQ Orbitrap Discovery features high
resolution and excellent mass accuracy for unequivocal characterization
of trace level, isobaric peptides. It provides high-throughput, label-
free profiling of differentially expressed analytes and, when combined
with the MSn capability, makes the instrument ideal for small molecule
characterization and structural elucidation.
-- Thermo Scientific LCQ Fleet(TM) Ion Trap Mass Spectrometer: This newest
addition to our LCQ line of ion trap mass spectrometers achieves cost-
effective, rapid and confident sample analysis for the general
analytical laboratory as well as for toxicological screening, natural
products characterization and peptide identification applications. The
robust and easy-to-use LCQ Fleet is ideal for routine compound
identification in complex matrices, providing maximum structural
information at lower detection levels and with low levels of sample
consumption.
-- Thermo Scientific TSQ Quantum GC(TM) Triple Quadrupole Mass
Spectrometer: This powerful GC-MS/MS instrument extends our TSQ
portfolio, providing higher sensitivity and lower detection limits for
regulated environmental, food, toxicology, pharmaceutical and clinical
research applications. An innovative scan function allows simultaneous
quantification and structural confirmation at the lowest limits of
quantitation. It is a highly sensitive and versatile GC triple
quadrupole mass spectrometer, and can switch easily between GC and LC
modes.
Other new technology developments to be announced by Thermo Fisher
Scientific at ASMS include:
-- Expansion of FAIMS technology to Thermo Scientific ion trap mass
spectrometers, including Orbitrap hybrids. This breakthrough technology
was introduced on Thermo Scientific Quantum triple quadrupole mass
spectrometers at ASMS 2006, and addresses the needs of scientists
requiring more definitive results and multiple modes of separation. The
FAIMS capability eliminates background interferences and allows
additional separation based on charge state, shape and molecular
conformation, which significantly improves specificity, spectral
quality and dynamic range.
-- Launch of novel Thermo Scientific Pierce(R) SILAC Protein Quantitation
Kits optimized for use with Thermo Scientific mass spectrometers. These
new SILAC (Stable Isotope Labeling with Amino Acids in Cell Culture)
kits provide comprehensive identification, characterization and
quantitation of cellular proteins, giving researchers an all-in-one
solution for the analysis of protein abundance. Published research and
poster presentations at ASMS will show application of SILAC, combined
with the LTQ Orbitrap and Thermo Scientific Hyclone cellular media, to
the elucidation of critical cellular protein pathways and interactions.
"We continue to deliver powerful new workflow tools for our customers
in the laboratory," noted Dr. Ian Jardine, vice president of global
research and development for Thermo Fisher Scientific. "We're bringing
together our best- in-class instrumentation, software and reagents to meet
the needs of researchers across many disciplines. Furthermore, we are
incorporating new technologies, such as ETD and FAIMS, into a wide range of
Thermo Scientific mass spectrometry systems to make these innovations
accessible to more scientists."
For more information on how Thermo Scientific is delivering mass
spectrometry innovation for every laboratory, visit http://www.thermo.com/ms.
Thermo Scientific is part of Thermo Fisher Scientific, the world leader
in serving science.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in
serving science, enabling our customers to make the world healthier,
cleaner and safer. With an annual revenue rate of more than $9 billion, we
employ 30,000 people and serve over 350,000 customers within pharmaceutical
and biotech companies, hospitals and clinical diagnostic labs,
universities, research institutions and government agencies, as well as
environmental and industrial process control settings. Serving customers
through two premier brands, Thermo Scientific and Fisher Scientific, we
help solve analytical challenges from routine testing to complex research
and discovery. Thermo Scientific offers customers a complete range of
high-end analytical instruments as well as laboratory equipment, software,
services, consumables and reagents to enable integrated laboratory workflow
solutions. Fisher Scientific provides a complete portfolio of laboratory
equipment, chemicals, supplies and services used in healthcare, scientific
research, safety and education. Together, we offer the most convenient
purchasing options to customers and continuously advance our technologies
to accelerate the pace of scientific discovery, enhance value for customers
and fuel growth for shareholders and employees alike. Visit
http://www.thermofisher.com.
The following constitutes a "Safe Harbor" statement under the Private
Securities Litigation Reform Act of 1995: This press release contains
forward- looking statements that involve a number of risks and
uncertainties. Important factors that could cause actual results to differ
materially from those indicated by such forward-looking statements are set
forth in the company's most recent Quarterly Report on Form 10-Q under the
caption "Risk Factors," which is on file with the Securities and Exchange
Commission and available in the "Investors" section of our Website under
the heading "SEC Filings." We also may make forward-looking statements
about the benefits of the merger of Thermo Electron and Fisher Scientific,
including statements about future financial and operating results, the new
company's plans, objectives, expectations and intentions and other
statements that are not historical facts. Important factors that could
cause actual results to differ materially from those indicated by
forward-looking statements include risks and uncertainties relating to: the
risk that the businesses will not be integrated successfully; the risk that
the cost savings and any other synergies from the transaction may not be
fully realized or may take longer to realize than expected; disruption from
the transaction making it more difficult to maintain relationships with
customers, employees or suppliers; competition and its effect on pricing,
spending, third-party relationships and revenues; the need to develop new
products and adapt to significant technological change; implementation of
strategies for improving internal growth; use and protection of
intellectual property; dependence on customers' capital spending policies
and government funding policies; realization of potential future savings
from new productivity initiatives; general worldwide economic conditions
and related uncertainties; the effect of changes in governmental
regulations; the effect of exchange rate fluctuations on international
operations; the effect of laws and regulations governing government
contracts; the effect of competing with certain of our customers and
suppliers; and the effect of rapid changes in the healthcare industry.
While we may elect to update forward-looking statements at some point in
the future, we specifically disclaim any obligation to do so, even if our
estimates change and, therefore, you should not rely on these
forward-looking statements as representing our views as of any date
subsequent to today.
Media Contact Information:
Lori Gorski
Phone: 781-622-1242
E-mail: lori.gorski@thermofisher.com
Investor Contact Information:
Ken Apicerno
Phone: 781-622-1111
E-mail: ken.apicerno@thermofisher.com
Website: http://www.thermofisher.com
SOURCE Thermo Fisher Scientific Inc.
 back to top
Related links:
http://www.thermofisher.com/
http://www.prnewswire.com/comp/877850.html/
CONTACT:
Media, Lori Gorski, +1-781-622-1242,
lori.gorski@thermofisher.com, or Investors, Ken Apicerno,
+1-781-622-1111, ken.apicerno@thermofisher.com, both of Thermo
Fisher Scientific Inc.
|
